This website is intended for UK healthcare professionals only. Not a UK healthcare professional? Click here.
Targeting Cholesterol: What do the guidelines recommend?
A focus on the recommendations around lipid modification therapy for the primary and secondary prevention of cardiovascular disease
Prof Derek Connolly & Beverley Bostock
Date: 03/02/2025
8 mins
Speaker bios
Professor Derek Connolly
Consultant Cardiologist and Director of R&D at Birmingham City Hospital
Derek is a Consultant Cardiologist at Birmingham City Hospital, Birmingham UK and holds honorary academic positions at both the University of Birmingham Institute of cardiovascular sciences and at Aston University medical School. Derek trained in Cambridge, London, Edinburgh and San Diego where he was a Carnegie Scholar. Derek has a first class degree in Pharmacology from the University of Edinburgh where he was the Brunton medallist and Keasbey Bursary holder. Derek’s PhD in molecular cardiology is from the University of Cambridge. Derek is the Chief or Primary Investigator of multiple large trials in Cardiovascular medicine. Derek developed one of the UKs first primary angioplasty programmes and one of the UKs largest cardiac CT programmes. He has been a council member of the PCCS since it’s refoundation.
Read More
Beverley Bostock
Advanced Nurse Practitioner in general practice in Gloucestershire and an Editor in Chief of Practice Nurse journal
She qualified as an RGN at St George’s Hospital London and gained a BSc in Professional Nursing Studies after completing 2 years of an advanced clinical practice MSc at Wolverhampton University. She is an Independent Nurse Prescriber and holds a PGDip in Diabetes, an MSc in Respiratory Care and an MA in Medical Ethics and Law. Beverley’s other qualifications include a Post Graduate Award in Diabetes Therapeutics from Warwick University. Beverley has extensive educational experience developing modules in diabetes and CVD for an Open University-affiliated organisation and is an Expert Witness for a clinical negligence company. She has been a Queen’s Nurse since 2015, a title which is given to nurses who have demonstrated a high level of commitment to patient care and nursing practice. Beverley is a President-Elect of the Primary Care Cardiovascular Society and has worked on the Implementation Steering Group of Public Health England’s CVDPREVENT project and Oxford AHSN’s ‘Prevention of CVD during the pandemic’ guidance. She has also been a Visiting Lecturer in behaviour change at Imperial College London for the MSc in Preventive Cardiology.
Read More
Abbreviations
AHSN, academic health science networks; BSC, Bachelor of Science; CT, clinical trial; CVD, cardiovascular disease; PhD, Doctor of Philosophy; MA, Master of Arts; MSc, Master of Sciences; PCCS, Primary Care Cardiovascular Society; RGN, Registered General Nurse; R&D, research and development; UK, United Kingdom.
Job code: UK/BIL/11/24/0011|Date of preparation: February 2025